|
Localization and Function of iNKT Cells in Neuroblastoma
|
5R01CA116548-03
|
$228,165
|
$228,165
|
METELITSA, LEONID
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Enhancing Activity of Alkylating Agents in Neuroblastoma
|
5R01CA082830-06
|
$62,346
|
$62,346
|
REYNOLDS, CHARLES
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Clinical Correlative Studies of Neuroblastoma
|
2R01CA060104-14A1
|
$408,898
|
$408,898
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-08
|
$1,899,503
|
$1,899,503
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Neuroblastoma Biology and Therapy
|
5P01CA097323-05
|
$2,216,467
|
$2,216,467
|
BRODEUR, GARRETT
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Gangliosides and the Biology of Human Neuroblastoma
|
5R01CA042361-16
|
$261,674
|
$209,339
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Complex ganglioside function in neuroblastoma
|
5R01CA106532-03
|
$247,903
|
$247,903
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
PEDIATRIC CHTN--AIDS CANCER RESEARCH
|
3U01CA054021-15S2
|
$828,868
|
$116,042
|
QUALMAN, STEPHEN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
N-myc Targeted Therapeutics for Childhood Neuroblastoma
|
5R44CA110885-03
|
$396,999
|
$396,999
|
Burkhart, Catherine
|
CLEVELAND BIOLABS, INC.
|
|
GENETIC ELEMENTS TRANSFORMING MOUSE FIBROBLASTS
|
5R01CA060730-13
|
$183,900
|
$25,746
|
GUDKOV, ANDREI
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Neuroblastoma Tumor Suppressor Genes in Zebrafish
|
5R01CA104605-04
|
$332,386
|
$332,386
|
LOOK, A
|
DANA-FARBER CANCER INSTITUTE
|
|
Camptothecin Analogs for Cancer Therapy
|
1R43CA125871-01A1
|
$158,895
|
$158,895
|
MORGAN, LEE
|
DEKK-TEC, INC.
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-24
|
$352,297
|
$10,569
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Phenotypic Plasticity in Human Neuroblastoma
|
5R01CA077593-06
|
$236,445
|
$236,445
|
ROSS, ROBERT
|
FORDHAM UNIVERSITY
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-24
|
$458,852
|
$4,589
|
BERNATH, ALBERT
|
GEISINGER MEDICAL CENTER
|
|
Neuropeptide Y in neuroblastoma: growth, angiogenesis and future therapeutics.
|
5R01CA123211-02
|
$265,208
|
$265,208
|
KITLINSKA, JOANNA
|
GEORGETOWN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA051008-16S3
|
$2,960,949
|
$59,219
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA051008-16S4
|
$110,862
|
$2,217
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
mTOR Signaling in Tumor Cell Motility
|
5R01CA115414-02
|
$201,997
|
$40,399
|
Huang, Shile
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
|
LSUHSC-Shreveport Feist-Weiller Cancer Center MBCCOP
|
1U10CA128567-01
|
$322,000
|
$3,220
|
MILLS, GLENN
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-36
|
$2,815,899
|
$28,159
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
CHEMISTRY AND BIOLOGY OF PLATINUM ANTICANCER DRUGS
|
5R37CA034992-25
|
$665,514
|
$133,103
|
LIPPARD, STEPHEN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Optimizing Immunotherapy for Neuroblastoma after BMT
|
5R01CA100030-04
|
$291,566
|
$291,566
|
JOHNSON, BRYON
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Nanodosing: A path to higher sensitivity and lower toxicity pharmaceuticals
|
1R44CA130394-01
|
$130,761
|
$65,381
|
Kronauge, James
|
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
|
|
Developing Nanodosing of Iobenguane I 131 for Radiotherapy
|
5R44CA115120-03
|
$351,359
|
$87,840
|
Kronauge, James
|
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
|
|
Children's Oncology Group Statistics and Data Center
|
5U10CA098413-05
|
$5,859,839
|
$175,795
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Community Clinical Oncology program Research Base
|
2U10CA095861-06
|
$1,567,888
|
$47,037
|
POLLOCK, BRADLEY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-05S2
|
$450,000
|
$13,500
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-05
|
$29,944,122
|
$898,324
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Human Specimen Banking in NCI-Supported Cancer Clinical
|
5U24CA114766-03
|
$1,133,628
|
$226,726
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Descriptive Studies and Record Linkage
|
Z01 CP010183
|
$674,691
|
$4,375
|
Anderson
|
DCEG (NCI)
|
|
Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Canc
|
Z01 SC 006880
|
$1,453,500
|
$290,700
|
Balis, Frank
|
CCR (NCI)
|
|
Developmental Signal Transduction in Xenopus Oocytes and Embryos
|
Z01 BC 010006
|
$689,247
|
$34,462
|
Daar, Ira
|
CCR (NCI)
|
|
"Infections, immunity, and inflammation in cancer"
|
Z01 CP010150
|
$726,292
|
$800
|
Engels
|
DCEG (NCI)
|
|
Comparative Genomic Hybridization of Neuroblastoma
|
Z01 BC 010592
|
$175,175
|
$175,175
|
Khan, Javed
|
CCR (NCI)
|
|
Molecular Mechanisms of Drugs
|
Z01 BC 010594
|
$87,588
|
$70,070
|
Khan, Javed
|
CCR (NCI)
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
Z01 BC 010806
|
$218,969
|
$120,433
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
Z01 SC 010366
|
$218,969
|
$153,278
|
Khan, Javed
|
CCR (NCI)
|
|
Immunobiology and Immunotherapy of Pediatric Tumors
|
Z01 SC 010289
|
$548,542
|
$164,563
|
Mackall, Crystal
|
CCR (NCI)
|
|
Role of Neurotrophins and Their Receptors in the Development of the Mammalian Ner
|
Z01 BC 010390
|
$506,846
|
$506,846
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
Z01 BC 010788
|
$373,696
|
$298,957
|
Thiele-Galetto, Carol
|
CCR (NCI)
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
Z01 BC 010789
|
$373,696
|
$298,957
|
Thiele-Galetto, Carol
|
CCR (NCI)
|
|
Histologic and Molecular Characterization of Solid Pediatric Tumors
|
Z01 SC 009431
|
$162,283
|
$8,114
|
Tsokos, Maria
|
CCR (NCI)
|
|
Regulation of apoptosis in Ewing's sarcoma and neuroblastoma
|
Z01 SC 010058
|
$324,567
|
$324,567
|
Tsokos, Maria
|
CCR (NCI)
|
|
Pediatric Oncology Branch Clinical Care and Education
|
Z01 BC 010764
|
$1,869,714
|
$186,971
|
Wayne, Alan
|
CCR (NCI)
|
|
Transcriptional regulation of NC precursor formation
|
5R01CA114058-03
|
$198,982
|
$99,491
|
LABONNE, CAROLE
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-14
|
$5,033,724
|
$50,337
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H.Lurie Comprehensive Cancer Center
|
3P30CA060553-13S5
|
$90,600
|
$906
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-14S1
|
$216,819
|
$2,168
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-14S2
|
$66,034
|
$660
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
Total relevant funding to Neuroblastoma for this search: $17,743,262
|